---
figid: PMC6291723__ajtr0010-3322-f4
figtitle: Main lipid-lowering effects of berberine through the APMK pathway
organisms:
- Homo sapiens
- Coptis chinensis
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6291723
filename: ajtr0010-3322-f4.jpg
figlink: /pmc/articles/PMC6291723/figure/fig04/
number: F4
caption: Main lipid-lowering effects of berberine through the APMK pathway. Briefly,
  LDLR mRNA can be stabilized by berberine through AMPK-dependent Raf-1 activation.
  Then, ERK is activated, and hnRNP D is down-regulated.
papertitle: Berberine is a potential therapeutic agent for metabolic syndrome via
  brown adipose tissue activation and metabolism regulation.
reftext: Xiaofei Hu, et al. Am J Transl Res. 2018;10(11):3322-3329.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9539181
figid_alias: PMC6291723__F4
figtype: Figure
redirect_from: /figures/PMC6291723__F4
ndex: f50f1c61-dee0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6291723__ajtr0010-3322-f4.html
  '@type': Dataset
  description: Main lipid-lowering effects of berberine through the APMK pathway.
    Briefly, LDLR mRNA can be stabilized by berberine through AMPK-dependent Raf-1
    activation. Then, ERK is activated, and hnRNP D is down-regulated.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COG2
  - LDLR
  - HNRNPC
  - HNRNPDL
  - HNRNPD
  - EPHB2
  - MAPK1
  - MAPK3
  - RAF1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - TG
  - LRP1
  - modSP
  - LpR2
  - mgl
  - Erk7
  - rl
  - Raf
  - SNF4Agamma
  - AMPKalpha
  - Tg
  - Berberine
---
